Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctioncalmodulin binding

UNC13B CACNA1A PDE1B ADD3 SLC24A4 AEBP1 KCNN1 SNTA1 PCNT

1.29e-052301239GO:0005516
GeneOntologyMolecularFunctionco-SMAD binding

USP9X SMAD2 SMAD3

4.82e-05121233GO:0070410
GeneOntologyBiologicalProcesshomophilic cell adhesion via plasma membrane adhesion molecules

PCDHGA4 FAT3 PCDHAC1 PCDHA1 CELSR1 PCDHGA12 PCDH10 PCDH9 PLXNB3

1.98e-061871249GO:0007156
GeneOntologyBiologicalProcesscell-cell adhesion via plasma-membrane adhesion molecules

CPLANE2 PCDHGA4 FAT3 PCDHAC1 PCDHA1 CELSR1 PCDHGA12 PTPRS PCDH10 PCDH9 PLXNB3

3.04e-0631312411GO:0098742
GeneOntologyBiologicalProcessembryo development ending in birth or egg hatching

TANC2 NCOA6 USP9X SPEG CECR2 APBA2 AMBRA1 ZEB2 ZFPM2 BPTF GJB3 CELSR1 FURIN TTLL4 SMAD2 TP53BP2 SMAD3 PCNT

1.12e-0592912418GO:0009792
GeneOntologyBiologicalProcesschordate embryonic development

TANC2 NCOA6 USP9X SPEG CECR2 APBA2 AMBRA1 ZEB2 ZFPM2 BPTF GJB3 CELSR1 FURIN TTLL4 SMAD2 SMAD3 PCNT

3.02e-0590612417GO:0043009
GeneOntologyBiologicalProcessin utero embryonic development

TANC2 NCOA6 USP9X SPEG APBA2 ZFPM2 BPTF GJB3 FURIN TTLL4 SMAD2 SMAD3 PCNT

6.27e-0559612413GO:0001701
GeneOntologyCellularComponentISWI-type complex

CECR2 BPTF BAZ2A

7.07e-05141243GO:0031010
DomainCadherin_CS

PCDHGA4 FAT3 PCDHAC1 PCDHA1 CELSR1 PCDHGA12 PCDH10 PCDH9

6.13e-071091238IPR020894
DomainCADHERIN_1

PCDHGA4 FAT3 PCDHAC1 PCDHA1 CELSR1 PCDHGA12 PCDH10 PCDH9

8.08e-071131238PS00232
DomainCadherin

PCDHGA4 FAT3 PCDHAC1 PCDHA1 CELSR1 PCDHGA12 PCDH10 PCDH9

8.08e-071131238PF00028
DomainCADHERIN_2

PCDHGA4 FAT3 PCDHAC1 PCDHA1 CELSR1 PCDHGA12 PCDH10 PCDH9

8.64e-071141238PS50268
Domain-

PCDHGA4 FAT3 PCDHAC1 PCDHA1 CELSR1 PCDHGA12 PCDH10 PCDH9

8.64e-0711412382.60.40.60
DomainCA

PCDHGA4 FAT3 PCDHAC1 PCDHA1 CELSR1 PCDHGA12 PCDH10 PCDH9

9.24e-071151238SM00112
DomainCadherin-like

PCDHGA4 FAT3 PCDHAC1 PCDHA1 CELSR1 PCDHGA12 PCDH10 PCDH9

9.87e-071161238IPR015919
DomainCadherin

PCDHGA4 FAT3 PCDHAC1 PCDHA1 CELSR1 PCDHGA12 PCDH10 PCDH9

1.12e-061181238IPR002126
DomainCadherin_2

PCDHGA4 PCDHAC1 PCDHA1 PCDHGA12 PCDH10 PCDH9

4.34e-06651236PF08266
DomainCadherin_N

PCDHGA4 PCDHAC1 PCDHA1 PCDHGA12 PCDH10 PCDH9

4.34e-06651236IPR013164
DomainCadherin_tail

PCDHGA4 PCDHAC1 PCDHA1 PCDHGA12

1.00e-04371234PF15974
DomainCadherin_CBD

PCDHGA4 PCDHAC1 PCDHA1 PCDHGA12

1.00e-04371234IPR031904
DomainCadherin_C

PCDHGA4 PCDHAC1 PCDHGA12 PCDH10

1.65e-04421234IPR032455
DomainCadherin_C_2

PCDHGA4 PCDHAC1 PCDHGA12 PCDH10

1.65e-04421234PF16492
DomainDDT

BPTF BAZ2A

2.56e-0441232PF02791
DomainDDT

BPTF BAZ2A

4.25e-0451232SM00571
DomainDDT_dom

BPTF BAZ2A

4.25e-0451232IPR018501
DomainWHIM1_dom

BPTF BAZ2A

4.25e-0451232IPR028942
DomainWHIM2_dom

BPTF BAZ2A

4.25e-0451232IPR028941
DomainWSD

BPTF BAZ2A

4.25e-0451232PF15613
DomainWHIM1

BPTF BAZ2A

4.25e-0451232PF15612
DomainDDT

BPTF BAZ2A

6.34e-0461232PS50827
DomainBromodomain_CS

CECR2 BPTF BAZ2A

6.49e-04261233IPR018359
DomainDWB

SMAD2 SMAD3

1.17e-0381232SM00524
DomainMH2

SMAD2 SMAD3

1.17e-0381232PS51076
DomainMH1

SMAD2 SMAD3

1.17e-0381232PS51075
Domain-

SMAD2 SMAD3

1.17e-03812323.90.520.10
DomainMAD_homology_MH1

SMAD2 SMAD3

1.17e-0381232IPR013019
DomainDwarfin

SMAD2 SMAD3

1.17e-0381232IPR013790
DomainMH2

SMAD2 SMAD3

1.17e-0381232PF03166
DomainSMAD_dom_Dwarfin-type

SMAD2 SMAD3

1.17e-0381232IPR001132
DomainBROMODOMAIN_1

CECR2 BPTF BAZ2A

1.84e-03371233PS00633
DomainBromodomain

CECR2 BPTF BAZ2A

1.99e-03381233PF00439
DomainCRAL_TRIO_N

SEC14L3 SEC14L2

2.28e-03111232PF03765
DomainBROMODOMAIN_2

CECR2 BPTF BAZ2A

2.48e-03411233PS50014
DomainBromodomain

CECR2 BPTF BAZ2A

2.65e-03421233IPR001487
DomainBROMO

CECR2 BPTF BAZ2A

2.65e-03421233SM00297
Domain-

CECR2 BPTF BAZ2A

2.65e-034212331.20.920.10
DomainMAD_homology1_Dwarfin-type

SMAD2 SMAD3

2.72e-03121232IPR003619
DomainDWA

SMAD2 SMAD3

2.72e-03121232SM00523
DomainCRAL-bd_toc_tran

SEC14L3 SEC14L2

2.72e-03121232IPR001071
DomainMH1

SMAD2 SMAD3

2.72e-03121232PF03165
DomainCRAL_TRIO_N

SEC14L3 SEC14L2

2.72e-03121232SM01100
DomainCRAL/TRIO_N_dom

SEC14L3 SEC14L2

4.27e-03151232IPR011074
DomainEMP24_GP25L

SEC14L3 SEC14L2

4.27e-03151232PF01105
DomainSMAD_dom-like

SMAD2 SMAD3

4.86e-03161232IPR017855
DomainAT_hook

CECR2 BAZ2A

4.86e-03161232PF02178
Domain-

SMAD2 SMAD3

4.86e-031612322.60.200.10
DomainZnf_RING-CH

MARCHF6 RNF139

5.48e-03171232IPR011016
DomainRINGv

MARCHF6 RNF139

5.48e-03171232SM00744
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

UNC13B TANC2 NCOA6 SZT2 SPEG AMBRA1 PFAS PLEKHG5 PCNX2 CELSR1 PWWP2B MDN1 ZNRF3 ZNF341 PTPRS ZMIZ2 FURIN TTLL4 SPEN PCNT

3.25e-0911051262035748872
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

UNC13B ZHX3 SPEG ZEB2 NEDD4 KANK1 BAZ2A PDE4DIP SPEN PCDH10 ZMYM3 PLXNB3 PCNT

3.30e-094071261312693553
Pubmed

Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.

PCDHGA4 PCDHAC1 PCDHA1 CELSR1 PCDHGA12 PCDH10 PCDH9

1.35e-0877126710835267
Pubmed

Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.

PCDHGA4 PCDHAC1 PCDHA1 CELSR1 PCDHGA12 PCDH10 PCDH9

1.77e-0880126710716726
Pubmed

RAP250 is a coactivator in the transforming growth factor beta signaling pathway that interacts with Smad2 and Smad3.

NCOA6 SMAD2 SMAD3

4.64e-083126318263591
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

UNC13B WAPL LEO1 TRPM7 USP9X HSPH1 APBA2 ZEB2 ADD3 MIA2 APPL2 PDE4DIP KCNN1 EIF3D SNTA1 SLX4 PLXNB3 SMAD2 PCNT

1.99e-0712851261935914814
Pubmed

A striking organization of a large family of human neural cadherin-like cell adhesion genes.

PCDHGA4 PCDHAC1 PCDHA1 CELSR1 PCDHGA12 PCDH10

2.58e-0772126610380929
Pubmed

Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.

PCDHGA4 PCDHAC1 PCDHA1 PCDHGA12 PCDH10 PCDH9

3.04e-0774126610817752
Pubmed

An activin/furin regulatory loop modulates the processing and secretion of inhibin alpha- and betaB-subunit dimers in pituitary gonadotrope cells.

FURIN SMAD2 SMAD3

4.62e-075126318826955
Pubmed

Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway.

ZEB2 SMAD2 SMAD3

4.62e-075126312743038
Pubmed

FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination.

USP9X SMAD2 SMAD3

9.21e-076126319135894
Pubmed

SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5'-CACCT sequences in candidate target genes.

ZEB2 SMAD2 SMAD3

9.21e-076126310400677
Pubmed

Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism.

ZBTB1 ZEB2 MIA2 ZNF341 ZMIZ2 PDE4DIP PCDH10 PCDH9 ZMYM3 TP53BP2

2.23e-064021261024722188
Pubmed

Cooperation of two ADAMTS metalloproteases in closure of the mouse palate identifies a requirement for versican proteolysis in regulating palatal mesenchyme proliferation.

SMAD2 SMAD3 EMCN

2.57e-068126321041365
Pubmed

Interaction between Smad-interacting protein-1 and the corepressor C-terminal binding protein is dispensable for transcriptional repression of E-cadherin.

ZEB2 SMAD2 SMAD3

2.57e-068126312714599
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

NCOA6 WAPL SZT2 CECR2 SRRM4 MARCHF6 AMBRA1 PLEKHG5 NACAD CASKIN2 TTLL4

3.83e-065291261114621295
Pubmed

NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.

NEDD4 SMAD2 SMAD3

3.84e-069126315496141
Pubmed

Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.

PCDHGA4 PCDHAC1 PCDHA1 PCDHGA12 PCDH10

5.00e-0668126511230163
Pubmed

Interaction network of human early embryonic transcription factors.

NCOA6 LIN9 ZEB2 PRDM2 BPTF ZMIZ2 SPEN SLX4 ZMYM3

5.73e-06351126938297188
Pubmed

Characterization of cDNA clones selected by the GeneMark analysis from size-fractionated cDNA libraries from human brain.

TANC2 ZNRF3 CASKIN2 KCNS2 SEC14L2

8.66e-0676126510574461
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

TANC2 CACNA1A PDE1B USP9X ZBTB1 ZEB2 NEDD4 PPP2R5D MDN1 PTPRS PDE4DIP PPP1R3F TP53BP2 PCNT

1.11e-059631261428671696
Pubmed

Mouse screen reveals multiple new genes underlying mouse and human hearing loss.

SEC16B MAGEA10 DONSON LEO1 SRRM4 IDE NACAD USP20 FADS3 MDN1 APPL2 ZNF341 TTLL4 KLF17 SLX4 PLXNB3

1.14e-0512421261630973865
Pubmed

Cep120 and TACCs control interkinetic nuclear migration and the neural progenitor pool.

CEP120 PDE4DIP PCNT

1.29e-0513126317920017
Pubmed

Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition.

SMAD2 SMAD3

1.30e-052126236050359
Pubmed

Receptor-regulated and inhibitory Smads are critical in regulating transforming growth factor beta-mediated Meckel's cartilage development.

SMAD2 SMAD3

1.30e-052126211984875
Pubmed

Polycomb determines responses to smad2/3 signaling in embryonic stem cell differentiation and in reprogramming.

SMAD2 SMAD3

1.30e-052126223666711
Pubmed

Phosphorylated Smad2/3 immunoreactivity in sporadic and familial amyotrophic lateral sclerosis and its mouse model.

SMAD2 SMAD3

1.30e-052126218210139
Pubmed

Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis.

SMAD2 SMAD3

1.30e-052126220010874
Pubmed

Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation.

SMAD2 SMAD3

1.30e-052126216382155
Pubmed

Evidence for a role of Smad3 and Smad2 in stabilization of the tumor-derived mutant Smad2.Q407R.

SMAD2 SMAD3

1.30e-052126212700238
Pubmed

Asthma-derived fibroblast to myofibroblast transition is enhanced in comparison to fibroblasts derived from non-asthmatic patients in 3D in vitro culture due to Smad2/3 signalling.

SMAD2 SMAD3

1.30e-052126233245228
Pubmed

Formation of the definitive endoderm in mouse is a Smad2-dependent process.

SMAD2 SMAD3

1.30e-052126210862745
Pubmed

Smad2-dependent downregulation of miR-30 is required for TGF-β-induced apoptosis in podocytes.

SMAD2 SMAD3

1.30e-052126224086574
Pubmed

Specific Smad2/3 Linker Phosphorylation Indicates Esophageal Non-neoplastic and Neoplastic Stem-Like Cells and Neoplastic Development.

SMAD2 SMAD3

1.30e-052126232705438
Pubmed

Smad2/3 Linker Phosphorylation Is a Possible Marker of Pancreatic Stem/Progenitor Cells in the Regenerative Phase of Acute Pancreatitis.

SMAD2 SMAD3

1.30e-052126228099259
Pubmed

Arsenite Disrupts Zinc-Dependent TGFβ2-SMAD Activity During Murine Cardiac Progenitor Cell Differentiation.

SMAD2 SMAD3

1.30e-052126226354774
Pubmed

Differential effects of Smad2 and Smad3 in regulation of macrophage phenotype and function in the infarcted myocardium.

SMAD2 SMAD3

1.30e-052126235780861
Pubmed

Constitutively Active SMAD2/3 Are Broad-Scope Potentiators of Transcription-Factor-Mediated Cellular Reprogramming.

SMAD2 SMAD3

1.30e-052126229174331
Pubmed

SMAD2/3 Phosphorylation Is Downregulated in T Cells in HIV-Infected Patients.

SMAD2 SMAD3

1.30e-052126236226468
Pubmed

Phosphorylation of Smad2/3 at specific linker threonine indicates slow-cycling intestinal stem-like cells before reentry to cell cycle.

SMAD2 SMAD3

1.30e-052126225185661
Pubmed

Increased TGF-β1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2/3 signaling.

SMAD2 SMAD3

1.30e-052126222228025
Pubmed

Oocyte-secreted factor activation of SMAD 2/3 signaling enables initiation of mouse cumulus cell expansion.

SMAD2 SMAD3

1.30e-052126217192514
Pubmed

TGFβ pathway deregulation and abnormal phospho-SMAD2/3 staining in hereditary cerebral hemorrhage with amyloidosis-Dutch type.

SMAD2 SMAD3

1.30e-052126228557134
Pubmed

Differential activation of noncanonical SMAD2/SMAD3 signaling by bone morphogenetic proteins causes disproportionate induction of hyaluronan production in immortalized human granulosa cells.

SMAD2 SMAD3

1.30e-052126226992562
Pubmed

Global analysis of Smad2/3-dependent TGF-beta signaling in living mice reveals prominent tissue-specific responses to injury.

SMAD2 SMAD3

1.30e-052126215972691
Pubmed

Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease.

SMAD2 SMAD3

1.30e-052126221732483
Pubmed

Smad2 and 3 transcription factors control muscle mass in adulthood.

SMAD2 SMAD3

1.30e-052126219357234
Pubmed

Smad2 and Smad3 have differential sensitivity in relaying TGFβ signaling and inversely regulate early lineage specification.

SMAD2 SMAD3

1.30e-052126226905010
Pubmed

Cigarette smoke exacerbates mouse allergic asthma through Smad proteins expressed in mast cells.

SMAD2 SMAD3

1.30e-052126221496353
Pubmed

Reduction of Smad2 caused by oxidative stress leads to necrotic death of hypertrophic chondrocytes associated with an endemic osteoarthritis.

SMAD2 SMAD3

1.30e-052126233769459
Pubmed

Acceleration of Smad2 and Smad3 phosphorylation via c-Jun NH(2)-terminal kinase during human colorectal carcinogenesis.

SMAD2 SMAD3

1.30e-052126215665291
Pubmed

Inhibiting Smad2/3 signaling in pluripotent mouse embryonic stem cells enhances endoderm formation by increasing transcriptional priming of lineage-specifying target genes.

SMAD2 SMAD3

1.30e-052126227012147
Pubmed

Opposing roles for Smad2 and Smad3 in peritoneal fibrosis in vivo and in vitro.

SMAD2 SMAD3

1.30e-052126224925688
Pubmed

Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo.

SMAD2 SMAD3

1.30e-052126215520018
Pubmed

Nuclear exclusion of SMAD2/3 in granulosa cells is associated with primordial follicle activation in the mouse ovary.

SMAD2 SMAD3

1.30e-052126230111581
Pubmed

The DNA binding activities of Smad2 and Smad3 are regulated by coactivator-mediated acetylation.

SMAD2 SMAD3

1.30e-052126217074756
Pubmed

Molecular validation of the precision-cut kidney slice (PCKS) model of renal fibrosis through assessment of TGF-β1-induced Smad and p38/ERK signaling.

SMAD2 SMAD3

1.30e-052126226919280
Pubmed

Smad2 and Smad3 expressed in skeletal muscle promote immobilization-induced bone atrophy in mice.

SMAD2 SMAD3

1.30e-052126234710825
Pubmed

Signaling via Smad2 and Smad3 is dispensable for adult murine hematopoietic stem cell function in vivo.

SMAD2 SMAD3

1.30e-052126228666967
Pubmed

The specific linker phosphorylation of Smad2/3 indicates epithelial stem cells in stomach; particularly increasing in mucosae of Helicobacter-associated gastritis.

SMAD2 SMAD3

1.30e-052126221229365
Pubmed

Signaling network crosstalk in human pluripotent cells: a Smad2/3-regulated switch that controls the balance between self-renewal and differentiation.

SMAD2 SMAD3

1.30e-052126222385658
Pubmed

Mice exclusively expressing the short isoform of Smad2 develop normally and are viable and fertile.

SMAD2 SMAD3

1.30e-052126215630024
Pubmed

Implication of Smad2 and Smad3 in transforming growth factor-β-induced posterior capsular opacification of human lens epithelial cells.

SMAD2 SMAD3

1.30e-052126224911914
Pubmed

Graded Smad2/3 activation is converted directly into levels of target gene expression in embryonic stem cells.

SMAD2 SMAD3

1.30e-052126219172185
Pubmed

The role of a Williams-Beuren syndrome-associated helix-loop-helix domain-containing transcription factor in activin/nodal signaling.

SMAD2 SMAD3

1.30e-052126211937490
Pubmed

The roles of Smad2 and Smad3 in the development of chemically induced skin tumors in mice.

SMAD2 SMAD3

1.30e-052126215133179
Pubmed

Oocytes determine cumulus cell lineage in mouse ovarian follicles.

SMAD2 SMAD3

1.30e-052126217389684
Pubmed

[Expression and significance of Smad2/3 and HPV16 E7 in cervical intraepithelial neoplasia and cervical carcinoma].

SMAD2 SMAD3

1.30e-052126217927854
Pubmed

Hydrophobic patches on SMAD2 and SMAD3 determine selective binding to cofactors.

SMAD2 SMAD3

1.30e-052126229588413
Pubmed

Neovibsanin B increases extracellular matrix proteins in optic nerve head cells via activation of Smad signalling pathway.

SMAD2 SMAD3

1.30e-052126226045877
Pubmed

Induction of Herpud1 expression by ER stress is regulated by Nrf1.

NFE2L1 HERPUD1

1.30e-052126225637874
Pubmed

Smad2/3 Activation Regulates Smad1/5/8 Signaling via a Negative Feedback Loop to Inhibit 3T3-L1 Adipogenesis.

SMAD2 SMAD3

1.30e-052126234445177
Pubmed

Essential role of Smad3 in angiotensin II-induced vascular fibrosis.

SMAD2 SMAD3

1.30e-052126216556868
Pubmed

Cell biology of Smad2/3 linker region phosphorylation in vascular smooth muscle.

SMAD2 SMAD3

1.30e-052126221883378
Pubmed

[The roles of Smad 2/3 in transforming growth factor-beta 1 signaling in human dental pulp cells].

SMAD2 SMAD3

1.30e-052126212760775
Pubmed

Differential Role of Smad2 and Smad3 in the Acquisition of an Endovascular Trophoblast-Like Phenotype and Preeclampsia.

SMAD2 SMAD3

1.30e-052126232733385
Pubmed

Smad2/3 linker phosphorylation is a possible marker of cancer stem cells and correlates with carcinogenesis in a mouse model of colitis-associated colorectal cancer.

SMAD2 SMAD3

1.30e-052126225908723
Pubmed

Expression pattern and phosphorylation status of Smad2/3 in different subtypes of human first trimester trophoblast.

SMAD2 SMAD3

1.30e-052126228864007
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

ZHX3 SEC16B NCOA6 WAPL LEO1 PRDM2 BPTF PWWP2B MDN1 BAZ2A SPEN ZMYM3

2.61e-057741261215302935
Pubmed

Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.

PCDHA1 MIA2 BAZ2A KCNN1 EIF3D SPEN TP53BP2 SMAD3

2.81e-05329126817474147
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

NCOA6 NEDD4 MIA2 AEBP1 NFE2L1 ZMIZ2 SPEN TP53BP2 PCNT

2.86e-05430126935044719
Pubmed

Induced pluripotent stem cell-conditioned medium suppresses pulmonary fibroblast-to-myofibroblast differentiation via the inhibition of TGF-β1/Smad pathway.

SMAD2 SMAD3

3.90e-053126229115383
Pubmed

Change in INSR, APBA2 and IDE Gene Expressions in Brains of Alzheimer's Disease Patients.

APBA2 IDE

3.90e-053126228164769
Pubmed

Osteosarcoma cells promote the production of pro-tumor cytokines in mesenchymal stem cells by inhibiting their osteogenic differentiation through the TGF-β/Smad2/3 pathway.

SMAD2 SMAD3

3.90e-053126224183998
Pubmed

TGFβ signalling is required to maintain pluripotency of human naïve pluripotent stem cells.

SMAD2 SMAD3

3.90e-053126234463252
Pubmed

Cell type-specific target selection by combinatorial binding of Smad2/3 proteins and hepatocyte nuclear factor 4alpha in HepG2 cells.

SMAD2 SMAD3

3.90e-053126221646355
Pubmed

Pin1 promotes transforming growth factor-beta-induced migration and invasion.

SMAD2 SMAD3

3.90e-053126219920136
Pubmed

The Sec14-like phosphatidylinositol transfer proteins Sec14l3/SEC14L2 act as GTPase proteins to mediate Wnt/Ca2+ signaling.

SEC14L3 SEC14L2

3.90e-053126228463110
Pubmed

Genomewide comprehensive analysis reveals critical cooperation between Smad and c-Fos in RANKL-induced osteoclastogenesis.

SMAD2 SMAD3

3.90e-053126225431176
Pubmed

Aspirin inhibits endometrial fibrosis by suppressing the TGF‑β1‑Smad2/Smad3 pathway in intrauterine adhesions.

SMAD2 SMAD3

3.90e-053126232323728
Pubmed

Increased Smad2/3 phosphorylation in circulating leukocytes and platelet-leukocyte aggregates in a mouse model of aortic valve stenosis: Evidence of systemic activation of platelet-derived TGF-β1 and correlation with cardiac dysfunction.

SMAD2 SMAD3

3.90e-053126227067480
Pubmed

Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesions.

SMAD2 SMAD3

3.90e-053126215166010
Pubmed

Asiaticoside hinders the invasive growth of keloid fibroblasts through inhibition of the GDF-9/MAPK/Smad pathway.

SMAD2 SMAD3

3.90e-053126228346732
Pubmed

Zinc-Alpha-2-Glycoprotein Peptide Downregulates Type I and III Collagen Expression via Suppression of TGF-β and p-Smad 2/3 Pathway in Keloid Fibroblasts and Rat Incisional Model.

SMAD2 SMAD3

3.90e-053126239105875
Pubmed

Identification of Small Molecules Which Induce Skeletal Muscle Differentiation in Embryonic Stem Cells via Activation of the Wnt and Inhibition of Smad2/3 and Sonic Hedgehog Pathways.

SMAD2 SMAD3

3.90e-053126226577380
Pubmed

Bovine lactoferrin enhances osteogenesis through Smad2/3 and p38 MAPK activation.

SMAD2 SMAD3

3.90e-053126232464258
Pubmed

Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development.

SMAD2 SMAD3

3.90e-053126220548029
Pubmed

Transcriptome analysis reveals autophagy as regulator of TGFβ/Smad-induced fibrogenesis in trabecular meshwork cells.

SMAD2 SMAD3

3.90e-053126231695131
Pubmed

Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis.

SMAD2 SMAD3

3.90e-053126214531804
Pubmed

p38 Mitogen-activated protein kinase affects transforming growth factor-beta/Smad signaling in human dental pulp cells.

SMAD2 SMAD3

3.90e-053126216924420
InteractionPCDHGB1 interactions

PCDHA1 CELSR1 PCDHGA12 PTPRS PCDH10 PCDH9

7.61e-06771236int:PCDHGB1
InteractionSPSB4 interactions

FAT3 MARCHF6 AMBRA1 CELSR1 PCDH10 PCDH9 HERPUD1

1.11e-051241237int:SPSB4
Cytoband5q31

SELENOP PCDHGA4 PCDHAC1 PCDHA1 PCDHGA12

1.73e-0511512655q31
Cytoband7p13

NACAD AEBP1 ZMIZ2

1.72e-043912637p13
CytobandEnsembl 112 genes in cytogenetic band chr7p13

NACAD AEBP1 ZMIZ2

4.28e-04531263chr7p13
CytobandEnsembl 112 genes in cytogenetic band chr22q12

SEC14L3 CSF2RB ZNRF3 EIF3D SEC14L2

4.97e-042351265chr22q12
GeneFamilyClustered protocadherins

PCDHGA4 PCDHAC1 PCDHA1 PCDHGA12

2.66e-046488420
GeneFamilySEC14 family|PRELI domain containing

SEC14L3 SEC14L2

3.47e-0468821063
GeneFamilySMAD family

SMAD2 SMAD3

6.43e-048882750
GeneFamilyNon-clustered protocadherins

PCDH10 PCDH9

1.50e-031288221
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZHX3 ZEB2

2.36e-0315882529
GeneFamilyZinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases

ZFPM2 L3MBTL1

2.69e-031688266
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

TRPM7 USP9X HSPH1 MARCHF6 ZEB2 PRDM2 SPEN TP53BP2

6.60e-081881268ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SELENOP PLEKHG5 ZEB2 F13A1 SLC24A4 SIGLEC10 SLC37A2 MS4A14

9.46e-081971268d95565652ca318a2298d6918d54ba6367e9560f4
ToppCellControl-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TRABD2B SPEG FAT3 ZFPM2 AEBP1 PTPRS SMAD3

1.14e-06189126745e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCelllymphoid-B_cell-Naive_B_cell|lymphoid / Lineage, cell class and subclass

ZEB2 PRDM2 FADS3 CD40 SLC9A7 PCDH9 HERPUD1

1.18e-061901267b8b05894e811e431d797ac4fa3ccff4963a154e7
ToppCelllymphoid-B_cell|lymphoid / Lineage, cell class and subclass

ZEB2 PRDM2 FADS3 CD40 SLC9A7 PCDH9 HERPUD1

1.18e-061901267c451de643ee08c2ff1093e807c65d724237473c5
ToppCellControl-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TRABD2B SPEG FAT3 ZFPM2 AEBP1 PTPRS SMAD3

1.23e-06191126714057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCellP28-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

TRABD2B PDE1B SPEG ITGA7 ZEB2 KANK1 AEBP1

1.27e-06192126787c7780cf72f4c204f2a5f6655309d47a23c08ae
ToppCellnucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

UNC13B TANC2 CECR2 SLC26A9 KANK1 ZNRF3 PCDH9

1.32e-061931267fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor

UNC13B TANC2 CECR2 SLC26A9 KANK1 ZNRF3 PCDH9

1.32e-061931267738f4f0a9ddde2432b429ab46838e353b1790589
ToppCellnucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

UNC13B TANC2 CECR2 SLC26A9 KANK1 ZNRF3 PCDH9

1.32e-061931267f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-immature_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

HSPH1 FADS3 PDE4DIP CD40 PCDH9 HERPUD1 SMAD3

1.46e-0619612679a6e4eea19348a6e3379d3b872456ab6280cb74f
ToppCellChildren_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

TRABD2B SPEG ITGA7 ZFPM2 GJB3 PCDH10

4.93e-0615312661524557514668f515ac1bbe847611f564b265b42
ToppCell343B-Fibroblasts-Fibroblast-D-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

CPLANE2 SLC26A9 F13A1 PWWP2B KCNN1 MS4A14

6.85e-0616212667860fab12893d2f589f91a89e33fbffeb4d6c56c
ToppCell343B-Fibroblasts-Fibroblast-D|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

CPLANE2 SLC26A9 F13A1 PWWP2B KCNN1 MS4A14

6.85e-061621266431dec235874245a0289aa1af98bdfb7ffe1c485
ToppCelldroplet-Heart-4Chambers-21m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZHX3 PDE1B PCDHGA4 ITGA7 ZFPM2 KANK1

1.21e-051791266b44e2d53b82c3c141bfc6539054b19708200a0d9
ToppCell10x5'v1-week_17-19-Myeloid_macrophage-stroma-monocytoid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

A2M SELENOP PLEKHG5 F13A1 PDE4DIP MS4A14

1.25e-051801266ba4c1fb55e8f1095bea6968417fefcf5f700926b
ToppCellGlobus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Tac2_(Substantia_Innominata_(SI),_dorsal,_bordering_GP)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

ENAM GJB3 MIA2 RP1L1

1.32e-05511264138c64f5f338ee82b04b03d827a3c8e997e5c9e4
ToppCellGlobus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Tac2_(Substantia_Innominata_(SI),_dorsal,_bordering_GP)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

ENAM GJB3 MIA2 RP1L1

1.32e-0551126456f500e6e6735f4df1f6709f4cf4b200d70c7093
ToppCellGlobus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Tac2_(Substantia_Innominata_(SI),_dorsal,_bordering_GP)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

ENAM GJB3 MIA2 RP1L1

1.32e-05511264050f8eee8378dadd556e18e7d8c8aa5437d184bf
ToppCellB_cell_maturation-immature_B_cell|World / Lineage and Cell class

CECR2 ZEB2 AEBP1 BAZ2A SLC9A7 PCDH9

1.33e-0518212662c7c51ebc4125d8a33454ffee0b143579ce5e451
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ZHX3 TRPM7 ABHD17C KANK1 PDE4DIP PCDH9

1.46e-05185126603f64a7132b13a01ba47187e0e15c13ac88f7cb2
ToppCelllymphoid-B_cell-Naive_B_cell|World / Lineage, cell class and subclass

PRDM2 FADS3 CD40 SLC9A7 PCDH9 HERPUD1

1.55e-051871266904ffd8cf4513e86fcd4c2b7faf24a34fbd2dce3
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

A2M CACNA1A PDE1B ZEB2 PCDH9 EMCN

1.55e-05187126615d6e158562d7d85af3ceaf955439b379c8fce81
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

A2M CACNA1A PDE1B ZEB2 PCDH9 EMCN

1.55e-051871266f62074b631fd45ad299c69d71b09267b04d656ee
ToppCelllymphoid-B_cell|World / Lineage, cell class and subclass

PRDM2 FADS3 CD40 SLC9A7 PCDH9 HERPUD1

1.55e-0518712662abbc01fd7f5b4e52113699625287893c991f8da
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

A2M SPEG FAT3 ITGA7 ZEB2 ZFPM2

1.70e-05190126670c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

BPTF AEBP1 CD40 PCDH9 HERPUD1 SMAD3

1.75e-051911266a073d58154c801ec499fd969f42b7f1ee7f15d79
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PRDM2 PWWP2B FADS3 CD40 SLC9A7 HERPUD1

1.75e-051911266b7d17d3ba488378b30f3732f8109f4a7c1673e61
ToppCellControl-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TRABD2B SPEG ZFPM2 AEBP1 PTPRS SMAD3

1.75e-051911266b133ee1c0e58d00ddd2e4e05b01fd04947524c18
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PWWP2B FADS3 CD40 SLC9A7 PCDH9 HERPUD1

1.91e-05194126636ce99b9e4e1c968cc7ae381168124cc7c14afb2
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

A2M SPEG ITGA7 ZEB2 ZFPM2 AEBP1

1.91e-051941266ebb038f94f49f5c655578d1b018676e10c6b7e3c
ToppCell10x5'-bone_marrow-Lymphocytic_B|bone_marrow / Manually curated celltypes from each tissue

PRDM2 AEBP1 CD40 SLC9A7 PCDH9 HERPUD1

1.96e-051951266bcbf0305ca9337a6f3021178dbb47a7fbf1030a4
ToppCellMild/Remission-B_naive-8|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)

ZEB2 BPTF PWWP2B FADS3 AEBP1 PCDH9

1.96e-0519512660a3221e4d1fa31a35868bdda0f0cc873c233b407
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SELENOP PLEKHG5 ZEB2 F13A1 SLC37A2 MS4A14

1.96e-05195126642bfdff88da1d07828c0ad65d412fb1752f0cee4
ToppCell10x5'v1-week_14-16-Lymphocytic_B-B_lineage-immature_B_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

ZEB2 AEBP1 PDE4DIP CD40 PCDH9 HERPUD1

1.96e-051951266ecaaa3d071e763c40d05d088fbf9e8ca06f78f47
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SPEG FAT3 ITGA7 ZEB2 ZFPM2 AEBP1

2.02e-0519612661522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

A2M SPEG ITGA7 ZEB2 ZFPM2 AEBP1

2.02e-051961266b8759e6231e0254797d6c30930407b79440c57bb
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HSPH1 CBARP ZBTB1 ZEB2 F13A1 SIGLEC10

2.02e-05196126601cea0bb0b938d0986fd2ddae06597b8af1768ee
ToppCell10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

UNC13B ITGA7 ABHD17C AEBP1 PCDH9 SEC14L2

2.02e-051961266b8b9801181d7604871b48aebacb295d0a57a5eaf
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SPEG FAT3 ITGA7 ZEB2 ZFPM2 AEBP1

2.02e-0519612661c8294014713684b50885e638668f2ce75f357f0
ToppCellPBMC-Severe-Lymphocyte-B-B_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

PRDM2 FADS3 CD40 SLC9A7 PCDH9 HERPUD1

2.08e-051971266368a7908435cb0d0feea135345e7179584a1e0cf
ToppCellParenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CA9 A2M TRABD2B SPEG ITGA7 AEBP1

2.14e-051981266bd42c03e384e64f61b02618cf1a5440033bb04b2
ToppCellBronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

UNC13B TANC2 CECR2 SLC26A9 KANK1 ZNRF3

2.14e-051981266f948391296c261c473d339069a6d0f20ccd6f38f
ToppCellParenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

UNC13B TANC2 CECR2 SLC26A9 KANK1 ZNRF3

2.14e-0519812662e2a4e1756bba6f4fbe529559a97d2993c890b4b
ToppCell3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PDE1B HSPH1 ZBTB1 ZEB2 SLC24A4 MS4A14

2.20e-0519912665b6feacb0ca92c3fc6b327be978320426dcf6f68
ToppCellkidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SELENOP PLEKHG5 ZEB2 F13A1 SLC37A2 MS4A14

2.20e-051991266e1066e638af83ba5e89c7cabb8ad00b6bcdee5f4
ToppCellTracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

A2M SPEG ITGA7 FADS3 AEBP1 KLF17

2.20e-0519912668ff0fdcbe9661b013913731ec8b53d84836ca865
ToppCellkidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SELENOP PLEKHG5 ZEB2 F13A1 SLC37A2 MS4A14

2.20e-051991266ca0f6526ba0dcf8789dd3b583291519626427f2f
ToppCellTracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

A2M TRABD2B ZFPM2 NEDD4 PDE4DIP PCDH9

2.26e-052001266b5a54b9baf79aea01f76a161f0a39bbe87eb4945
ToppCellBronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

A2M TRABD2B FAT3 ZFPM2 AEBP1 PTPRS

2.26e-052001266389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCellTracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

A2M TRABD2B ZFPM2 NEDD4 PDE4DIP PCDH9

2.26e-052001266f5bd0b30e478dac09f68c46b0781f5f2e7e3c693
ToppCellParenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

A2M FAT3 ZEB2 ZFPM2 AEBP1 PTPRS

2.26e-052001266cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCellTracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

A2M TRABD2B ZEB2 ZFPM2 AEBP1 PCDH9

2.26e-052001266c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

A2M FAT3 ZEB2 ZFPM2 AEBP1 PTPRS

2.26e-052001266311fab076f2ceb258e3970eb21e39344b894042a
ToppCellfacs-Large_Intestine-Proximal-3m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GRK1 SEC14L3 ENAM SLC24A4 PCDH10

6.38e-051481265dfd3f2c4b884ea9e23831a242a89ac985b409640
ToppCellsaliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

LEO1 USP20 NEDD4 MDN1 PTPRS

1.01e-041631265130c84bca3f72ab7d1a4fee2990c3d01600318ed
ToppCellChildren_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

A2M TRABD2B SPEG ZFPM2 PCDH10

1.04e-041641265e3983f655cdba308fb192182829f17bef99ce0ba
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

WAPL CELSR1 CD40 SLC9A7 PCDH9

1.07e-041651265fead3f2032f8fa5f7f0159a4434989b3d65debbb
ToppCellAdult-Immune-interstitial_macrophage_(C1Q_positive)-D122|Adult / Lineage, Cell type, age group and donor

SELENOP PDE1B ZEB2 F13A1 SLC37A2

1.10e-041661265be284e2e596390f05305c7bcfc316f87b963fc0b
ToppCellCOVID-19-APC-like-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations)

PDE1B BTBD18 PLEKHG5 F13A1 ZNF341

1.13e-041671265854a5dbd43f2b25825a71d37fd7779507783a99a
ToppCellNS-moderate-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CSF2RB AEBP1 PTPRS PCDH9 HERPUD1

1.16e-041681265d03e91f0e0518b33555c0ec98124fc5ed0f11be5
ToppCell3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CECR2 SRRM4 PCDHAC1 CBARP PTPRS

1.19e-041691265606aa4ff25380d9470ec116ca86cd20f8b19587a
ToppCell3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CECR2 SRRM4 PCDHAC1 CBARP PTPRS

1.19e-041691265052aae2af5446a0de071d5dda5381b0b9a0ed54d
ToppCellTCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-6|TCGA-Liver / Sample_Type by Project: Shred V9

PDE1B ZEB2 ZFPM2 PCDHGA12 KCNS2

1.19e-041691265e992530776cab922d0360b275fb9cb8bd0017b06
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

A2M ITGA7 ZEB2 AEBP1 PCDH10

1.30e-0417212651ef243bce63d841c25e4b74d029d1377f84bcc3d
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ZEB2 CSF2RB SIGLEC10 SLC37A2 MS4A14

1.30e-04172126572fbfa890995e47048b47199c170cc7dcd7661f8
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ZEB2 CSF2RB SIGLEC10 SLC37A2 MS4A14

1.30e-0417212652ca6f0d1181aabe0d0e3e8f2e193f08dbda42dea
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

A2M ITGA7 ZEB2 AEBP1 PCDH10

1.30e-041721265ab1c81be29f93ca8920c6ab5ab92f497a9256d3f
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TRABD2B TRPM7 CECR2 SRRM4 KANK1

1.33e-0417312654bc6d93716f093b460c8b047199db8cab5fea720
ToppCellControl-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class

A2M SELENOP F13A1 CELSR1 FBXL18

1.37e-0417412654c64ff5666812fb4efa440ba4faeca51d916d68e
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

A2M PCDHAC1 ZEB2 PCDH9 EMCN

1.40e-0417512651b4cefae400bf756d09ece32d3f5c0bd4c6ad73f
ToppCellPBMC-Mild-cDC_11|Mild / Compartment, Disease Groups and Clusters

TANC2 SLC24A4 CASKIN2 SIGLEC10 SNTA1

1.48e-041771265974305e4c0eff90134c4e58cf11b955d1eee0501
ToppCellChildren_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

TRABD2B SPEG ITGA7 ZFPM2 PCDH10

1.48e-041771265b59967219f7d874805768e247c0eb2bc4d4420c8
ToppCellfacs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LEO1 PCDHGA4 ITGA7 FADS3 MDN1

1.48e-0417712657c3d46ebd7e8726be6871aa9763e281fc0ec6ac8
ToppCellfacs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LEO1 PCDHGA4 ITGA7 FADS3 MDN1

1.48e-041771265e7b1f3092e6b8d0d580f82648035f5ad12be6961
ToppCelldroplet-Marrow-nan-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FAT3 PLEKHG5 NEDD4 CSF2RB PTPRS

1.48e-041771265c1f838e425ebb04482829b1957e3c1347127e6de
ToppCellTCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9

ZEB2 F13A1 AEBP1 PCDHGA12 KLF17

1.52e-041781265142879e9393e721f9b05a6bb46995c9d6d713c95
ToppCellfacs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SEC16B FAT3 PLEKHG5 NEDD4 CSF2RB

1.52e-04178126541745a589567ca5ea6d06331f4c8da03595b5f5c
ToppCellfacs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SEC16B FAT3 PLEKHG5 NEDD4 CSF2RB

1.52e-041781265eb940dd64c973f68bcaad6069d3bd56383329db5
ToppCellprimary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Rassf10|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

KANK1 CASKIN2 CD40 PLXNB3

1.53e-049512640ac6cba7e0ed6083f777287f39a871461fa1bca4
ToppCellControl-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations)

UNC13B TANC2 CECR2 KANK1 PCDH9

1.60e-041801265198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCellControl-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations)

SPEG FAT3 ITGA7 ZFPM2 AEBP1

1.60e-041801265d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

A2M CACNA1A ZEB2 PCDH9 EMCN

1.64e-041811265a2058d658f07ab6f0a28d2622f3090b4cde6f763
ToppCellSevere-Lymphoid-pDC|Severe / Condition, Lineage, Cell class and cell subclass

AEBP1 PTPRS SLC9A7 PCDH9 HERPUD1

1.64e-0418112652caecb7c5dcdad46fd02b4ffb73cb613ce835187
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

FADS3 AEBP1 CD40 PCDH9 HERPUD1

1.64e-041811265ca34d83daca10c5fa52ecdf4eba7d31b4e7e056e
ToppCelldroplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PPHLN1 ZBTB1 ZEB2 FBXL18 SLX4

1.64e-0418112653fe648db1cb8326066d8bde3ca1287c5c9af19bd
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

A2M CACNA1A ZEB2 PCDH9 EMCN

1.64e-041811265526e858a848470b6d2d5248788004d9735ed3add
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TRABD2B TRPM7 CECR2 SRRM4 KANK1

1.64e-041811265e0abf2707d9e0aa942c657eef7d2cbcd02f060dd
ToppCell3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HSPH1 ZBTB1 PRDM2 CD40 HERPUD1

1.64e-041811265d66838fca0429cad2079cd8d92a5cd33eb0d3522
ToppCellSevere-Lymphoid-pDC-|Severe / Condition, Lineage, Cell class and cell subclass

AEBP1 PTPRS SLC9A7 PCDH9 HERPUD1

1.64e-041811265277ce4c49121da0990a5933b19d2c6af9bbe253e
ToppCellfacs-Skin-Anagen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CECR2 SLC6A2 CELSR1 ZNRF3 HERPUD1

1.69e-04182126522d6f4790950508e8aa27e02a8133af5f53f13c8
ToppCellfacs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

UNC13B APBA2 ENAM CELSR1 EMCN

1.69e-041821265d22ab50b135482915687c70e6dad29bfe2bb2c68
ToppCellT_cells-Resident_memory_CD8+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis

APBA2 NACAD USP20 PDE4DIP SNTA1

1.69e-041821265111d434b89902ec11fb07f41b8ee1a98f3991b61
ToppCellAdult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor

FAT3 PFAS ITGA7 AEBP1 CD40

1.69e-041821265ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8
ToppCellfacs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

UNC13B TANC2 KANK1 FADS3 RP1L1

1.73e-04183126512e876d6205af8aad74265c668b5e95b9e7487f3
ToppCellBasal|World / shred by cell class for mouse tongue

TRABD2B NEDD4 CELSR1 PTPRS FURIN

1.73e-041831265c6729a207526ff4aa48176207b9353176f631fea
ToppCelldroplet-Heart-4Chambers-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

UNC13B A2M CELSR1 KANK1 EMCN

1.73e-0418312656c4a09c02e30e1f24dde39f8cb8c5b453826ee2e
ToppCellControl-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TRABD2B FAT3 ZFPM2 PTPRS SMAD3

1.73e-0418312657eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCellPericytes-Donor_07|World / lung cells shred on cell class, cell subclass, sample id

A2M ITGA7 NACAD AEBP1 PPP1R3F

1.77e-0418412653d2d55d0f22874be21665ab37da710482f77fc36
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HSPH1 ZBTB1 PRDM2 CD40 HERPUD1

1.82e-041851265e913c64f9b4873443d88dce270f0b7b6d1b4cbce
DrugDOTP

IDE POLK TP53BP2

1.36e-0591263CID000129981
DrugDizocilpine maleate [77086-22-7]; Down 200; 11.8uM; MCF7; HT_HG-U133A

CACNA1A APBA2 USP20 PCNX2 GJB3 BAZ2A PDE4DIP EMCN

1.38e-0519612682232_DN
DrugAlthiazide [5588-16-9]; Up 200; 10.4uM; MCF7; HT_HG-U133A

MARCHF6 TLX3 BRME1 F13A1 FBXL18 TTLL4 SLC9A7 SNTA1

1.43e-0519712686089_UP
DrugSB 203580; Up 200; 1uM; PC3; HT_HG-U133A

PRR4 USP20 PRDM2 PCNX2 MIA2 BAZ2A ZMIZ2 SMAD3

1.43e-0519712687066_UP
DrugImipenem [74431-23-5]; Up 200; 13.4uM; HL60; HG-U133A

SZT2 AMBRA1 FBXL18 L3MBTL1 TTLL4 KCNN1 SNTA1 SMAD3

1.60e-0520012681724_UP
DiseaseCerebral Palsy, Spastic Quadriplegic, 1

ADD3 KANK1

4.99e-0531212C2751938
Diseasecoronary artery disease

ZHX3 NCOA6 TRPM7 SRRM4 PPHLN1 ZEB2 F13A1 ZFPM2 NEDD4 ENAM CEP120 FURIN HERPUD1 SMAD2 SMAD3

1.14e-04119412115EFO_0001645
Diseaselevel of Phosphatidylcholine (O-16:0_16:1) in blood serum

PCDH10 HERPUD1

1.65e-0451212OBA_2045112
Diseaseheparan sulfate glucosamine 3-O-sulfotransferase 3A1 measurement

ZFPM2 ADD3

2.47e-0461212EFO_0801671
DiseaseLoeys-Dietz Syndrome

SMAD2 SMAD3

3.46e-0471212C2697932
Diseasemetachronous colorectal adenoma

FAT3 PTPRS EMCN

8.42e-04451213EFO_0803377
Diseasesuntan

NCOA6 SLC24A4 ZNF341 SNTA1

8.70e-041031214EFO_0004279
DiseaseHMG CoA reductase inhibitor use measurement

ZHX3 FURIN HERPUD1 SNTA1 SMAD3

1.12e-031891215EFO_0009932
Diseasetotal cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement

ZHX3 POLK HERPUD1

1.21e-03511213EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928
Diseaselevel of Phosphatidylcholine (16:0_18:3) in blood serum

FADS3 HERPUD1

1.26e-03131212OBA_2045072
Diseaselevel of Phosphatidylcholine (O-18:1_20:4) in blood serum

FADS3 HERPUD1

1.69e-03151212OBA_2045131
Diseasepuberty onset measurement

SEC16B PRICKLE4 NCOA6 PRDM2

1.78e-031251214EFO_0005677
Diseasecochlin measurement

ZFPM2 NFE2L1

1.93e-03161212EFO_0801481
Diseaserenal cell carcinoma (is_marker_for)

CA9 PFAS KANK1 SMAD2

1.94e-031281214DOID:4450 (is_marker_for)
Diseasetriglycerides to total lipids in very large HDL percentage

BPTF CD40 HERPUD1

2.13e-03621213EFO_0022339
DiseaseAmelogenesis imperfecta

ENAM SLC24A4

2.18e-03171212cv:C0002452
Diseasenon-word reading

SLC24A4 ZMIZ2 HERPUD1

2.66e-03671213EFO_0005299
Diseasediet measurement, HOMA-B

FAT3 PCNX2

2.72e-03191212EFO_0004469, EFO_0008111
Diseasetotal cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer

ZHX3 POLK HERPUD1

2.89e-03691213EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992
Diseasechildhood trauma measurement, alcohol consumption measurement

TANC2 PCDHGA4 PCDHGA12

3.14e-03711213EFO_0007878, EFO_0007979
DiseaseLeft Ventricle Remodeling

SMAD2 SMAD3

3.33e-03211212C0600520
DiseaseVentricular Remodeling

SMAD2 SMAD3

3.33e-03211212C0600519
Diseasemigraine disorder

CACNA1A WAPL AMBRA1 ZEB2 ABHD17C KANK1

3.61e-033571216MONDO_0005277
DiseaseSarcosine measurement

PCDHGA4 PPP2R5D

3.99e-03231212EFO_0021668

Protein segments in the cluster

PeptideGeneStartEntry
AQLSGQPDPVPQLSD

ACCSL

111

Q4AC99
EQQQPPLEPDAERDA

CBARP

411

Q8N350
AAEDPVQPNAPRNNV

CACNA1A

1261

O00555
NPGPQVADFNPETRQ

ARL14EPL

46

P0DKL9
EDPNQFVPLNTNPNE

ADD3

486

Q9UEY8
PEELPQEGGAPLSNN

AEBP1

191

Q8IUX7
GQDSEQPQAQLQPEA

BAZ2A

1211

Q9UIF9
ENTEEAQPQPQPQPQ

PPP2R5D

31

Q14738
SDLNGPVDNNNIPET

APBA2

331

Q99767
LVDQNDNPPVLPDFQ

CELSR1

1091

Q9NYQ6
NPSNQQGDDEPEIPI

AMBRA1

201

Q9C0C7
SPNANNDQPEDLIQG

BPTF

1251

Q12830
NPGRAPENSEAQEPE

CECR2

956

Q9BXF3
AQEPENDQAEPLPGL

CECR2

966

Q9BXF3
GVPDNSPNLQNNPEE

TP53BP2

836

Q13625
SPNLQNNPEEPNPEA

TP53BP2

841

Q13625
PGPLNDQDNEDCINR

A2M

631

P01023
VEAPGDPQEPQNNAH

CA9

116

Q16790
NGNVPVENPEDPQQN

SLC24A4

376

Q8NFF2
EAVPSESEPPALQNN

NFE2L1

281

Q14494
NPEDPAEAAQQLGRP

RILP

221

Q96NA2
SQEQPLDAQQGPPEP

P3H1

706

Q32P28
LDAQQGPPEPAQESL

P3H1

711

Q32P28
NVADTNDNPPVFPQA

PCDHGA12

441

O60330
QNFPNDGPPPDVVNQ

HERPUD1

316

Q15011
DGPPPDVVNQDPNNN

HERPUD1

321

Q15011
TKGDPNLQQAPPNTD

PCDHGA4

831

Q9Y5G9
APGESQQEEPPTDNQ

PAGE4

26

O60829
QQEEPPTDNQDIEPG

PAGE4

31

O60829
PGTPENGNDQPQSDK

EMCN

221

Q9ULC0
APLQQPDPAQAAVEG

FAM201A

106

Q5SY85
NGLPQDQQEEEPIPE

LEO1

341

Q8WVC0
DQNESQSPQEPEEGP

MDN1

4931

Q9NU22
LAPDQGLQPADQPTD

LIN9

416

Q5TKA1
ADDETPNPPQSAQIA

MAGEA10

76

P43363
QSPPEGEDVQSPLQN

MAGEC1

116

O60732
PTPQDNLTDAENGNI

NEDD4

641

P46934
PGSPRGQPQDQDDDE

KCNN1

56

Q92952
ENPLAANENVSPGIP

ZFPM2

1081

Q8WW38
PPENPDTDKNVQQDN

HSPH1

521

Q92598
SSQQDQEEPEVQGPP

CARMIL3

1316

Q8ND23
NQKEGPLQPLPSNND

PCNX2

721

A6NKB5
AEVQASRAQPQDPQP

PLXNB3

1056

Q9ULL4
GPQQAEDHPQNPPED

L3MBTL1

141

Q9Y468
DENDNPPIFNQPVIE

PCDH9

461

Q9HC56
PPSPAEDEHNQNGNL

PDE1B

521

Q01064
VDPQEDPQNAPDVNY

GPS1

21

Q13098
QQEDSGEQPLPPTSN

GHDC

106

Q8N2G8
DFQIPDSQGNPGEDP

KCNS2

211

Q9ULS6
DDPVGESLENPQPQA

KANK1

801

Q14678
ENVAADQPANPPAEN

MARCHF6

201

O60337
DQPANPPAENAVVGE

MARCHF6

206

O60337
PPAENAVVGENPDAQ

MARCHF6

211

O60337
PPNNSNAAEDDLPTV

F13A1

16

P00488
DQNDNAPAIVAPLPG

PCDH10

566

Q9P2E7
EQQPLAAGAAPPELQ

PCNT

1906

O95613
NAQPLPSAGEDQVLP

CASKIN2

436

Q8WXE0
FQLDNPDPQPIVDGE

PTPRS

1266

Q13332
QEGPMDQQDPENPVA

PASD1

316

Q8IV76
DQQDPENPVAPLDQA

PASD1

321

Q8IV76
ANLDLSGNPRQPNPD

PCDHA1

791

Q9Y5I3
PQPQQELFVAENNGP

PCDHAC1

446

Q9H158
EEADQPPLPGEQGIN

NCOA6

941

Q14686
SPQQENRPGDKAEAP

PRICKLE4

266

Q2TBC4
QDSPQIPDPGGDFQE

BTBD18

381

B2RXH4
QDQVAAGLLPNPPES

CPLANE2

241

Q9BU20
EPAENQDNPEDPGNS

SLC37A2

246

Q8TED4
DSQPGDEAQPQNLEC

CSF2RB

236

P32927
DPLQEPGAQQGIPDT

BRME1

491

Q0VDD7
TNEPFNDLINPNFEP

CEP120

231

Q8N960
ASFDVNDQDPDPQPR

FURIN

171

P09958
NEPPQDEGNSFNSPR

EIF3D

296

O15371
LVNDVNDNPPIFDQP

FAT3

2276

Q8TDW7
AAAAQPAPQQPEEGA

ABHD17C

66

Q6PCB6
VLLNDQPDDDDGNPN

APPL2

641

Q8NEU8
QPPDLQPENTEPQNQ

MS4A14

436

Q96JA4
QPEAPVPFLDSNQEN

DONSON

101

Q9NYP3
DPQANNNNGEQDSPP

KLF17

371

Q5JT82
NDINLSQAPALPQPE

IDE

976

P14735
TNLPSDPAQPQADGD

ITGA7

736

Q13683
QPSHNQPQPEEEAQP

ENAM

141

Q9NRM1
NVNEENPGFPEPRAL

GRK1

281

Q15835
VDPDPGNNKLQASAP

GJB3

251

O75712
LAPEEPSQDGPLNAQ

FADS3

96

Q9Y5Q0
SLEPFRPQQAPQDDG

PWWP2B

276

Q6NUJ5
RPQQAPQDDGSQDPE

PWWP2B

281

Q6NUJ5
ENVQDVLPALPNPDD

SEC14L2

21

O76054
ENVQDVLPALPNPDD

SEC14L3

21

Q9UDX4
ENEGEETAQSAPQPP

PPHLN1

366

Q8NEY8
LEEPQPPAEQAQATQ

PRDM2

521

Q13029
QPQDANALEPPLNGD

FAM114A1

71

Q8IWE2
AEESNPPLQDFPNSI

MIA2

331

Q96PC5
VSNNNGFIPPNETPE

RNF139

601

Q8WU17
ELPIQNEPPGQAAAE

SZT2

846

Q5T011
QPENNGADTGPEQPL

SLC6A2

11

P23975
ENSPATPPDEQGQGD

USP9X

41

Q93008
PREQEPAQLNGAAEP

SNTA1

56

Q13424
QELQQDFENAPPTDP

SLC26A9

596

Q7LBE3
DFENAPPTDPNNNQT

SLC26A9

601

Q7LBE3
SGLQPQPPEQLENEL

FBXL18

781

Q96ME1
QPQQQLPEEAEPEPQ

TANC2

1386

Q9HCD6
SELSENQQPGAPNAP

SELENOP

221

P49908
APPGLNDDAQIPASQ

SLX4

1686

Q8IY92
AQEPPGSQQPLQSLE

PLEKHG5

691

O94827
QSVNAPPAIQPLDDE

ZNF341

36

Q9BYN7
DLQPPAGAQALQPSE

SPEN

2246

Q96T58
QGRAPSQDQEAPSPE

SPEG

1976

Q15772
QQSLEGDPGQDPEPE

RP1L1

1011

Q8IWN7
SDQLQQQDPPGPASS

TRABD2B

476

A6NFA1
PENTNFPAGIEPQSN

SMAD2

201

Q15796
PENTNFPAGIEPQSN

SMAD3

161

P84022
DDDGNPTEQYPLNPN

PFAS

1261

O15067
EPQNNPVVPAQDGPS

SRRM4

46

A7MD48
QPPGDPFQVNFEEQN

POLK

261

Q9UBT6
PEQEVAPPSGQQALQ

TXLNGY

71

Q9BZA5
PSLQPPPESNDNSQD

WAPL

486

Q7Z5K2
PTPTDAEGLPQQQQL

PPP1R3F

291

Q6ZSY5
QLQEIPDDGDPSLPQ

UNC13B

386

O14795
DNEPPGPIDNSRIAQ

USP20

836

Q9Y2K6
DNRGSPQPQQEPRAD

SEC16B

51

Q96JE7
DQILNSPDQDSAPAP

TLX3

21

O43711
DSGNQDDGPQQRPPK

PRR4

61

Q16378
GPPDLPTNNNDDLLS

ZMIZ2

901

Q8NF64
RPPNNSSPVQEDAEN

ZBTB1

406

Q9Y2K1
NPEAIDQLNQGSEDP

ZNRF3

161

Q9ULT6
PQDNENPPQQGEANQ

ZNF788P

6

Q6ZQV5
ANGQEENDLPPGTPD

ZEB2

191

O60315
VDPDQDPPPNNDSFQ

SLC9A7

561

Q96T83
DPPPNNDSFQVLQGD

SLC9A7

566

Q96T83
SRDNTPALEPQPQGN

SIGLEC10

246

Q96LC7
PPAVNQQFPQEDAGS

TTLL4

381

Q14679
EAQPAETLPEGPQQD

ZHX3

26

Q9H4I2
FPQDEPSDLNLQPGN

TRPM7

1836

Q96QT4
EEELPQGQPQSPNAP

ZMYM3

176

Q14202
AQQQRPIPQSGDPAD

ZMYM3

391

Q14202
QEPQEINFPDDLPGS

CD40

231

P25942
EPAALDQVQQDDPQP

NACAD

991

O15069
DQVQQDDPQPAAEAG

NACAD

996

O15069
QLDNQSQPRDPGPQS

PDE4DIP

1191

Q5VU43